• Toxoplasma gondii, Molecular Detection, PCR
  • PPP2R2B (Protein Phosphatase 2 Regulatory Subunit Beta) Gene Mutation Analysis
  • Hemoglobin, Free, Plasma
  • 17-Ketosteroids, Urine
  • Beta-Lactoglobulin, IgE
  • BCR-ABL, Translocation, FISH, Blood
  • Biopsy, Head and Neck
  • Prenatal RhD NIPT Cell-free DNA Screening (UNITY Fetal Antigen™, Fetal RhD NIPT Panorama™)
  • MDM2 Gene Amplification, FISH
  • Fibrinogen Antigen
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
Medical Test

Turnaround Time
Access to Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management is restricted.
Loading...